Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1241-1250 of 10616

Edit search filters
  1. A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

  2. A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

    Scottsdale/Phoenix, AZ

  3. Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension

    Jacksonville, FL

  4. Glaucoma Biomarkers

    Rochester, MN

  5. Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures

    Jacksonville, FL

  6. Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Tailored Antiplatelet Therapy Following PCI

    La Crosse, WI, Eau Claire, WI, Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study to Detect Minimally-Invasive Barrett's Esophagus and Barrett's Esophagus Related Dysplasia/Carcinoma

    Rochester, MN, Jacksonville, FL, Austin, MN, Scottsdale/Phoenix, AZ

  10. A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer